Also, the research has demonstrated that plectin is a potential biomarker for intraductal papillary mucinous neoplasms (IPMN) of the pancreas, facilitating the differentiation between benign and malignant IPMN [61]. This evidence concerns the gene PLEC and pancreatic intraductal papillary-mucinous neoplasm.